US2007037229A1PendingUtilityA1
Altered Intracellular Localization of BRK/Sik Protein Tyrosine Kinase in Human Prostate Tumors
Est. expiryJan 11, 2022(expired)· nominal 20-yr term from priority
G01N 33/57555C12Q 1/485C12Q 1/6886C12Q 2600/158
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods for detecting abnormal prostate conditions, such as benign prostatic hyperplasia (BPH), prostatic intraepithelial neoplasia (PIN), and adenocarcinoma, in an animal by comparing the amount of the Breast Tumor Kinase (BRK) tyrosine kinase in the nuclei of prostate luminal epithelial cells in a test sample with an amount of nuclear BRK protein in epithelial cells of normal prostate glands.
Claims
exact text as granted — not AI-modified1 . A kit for detecting an abnormal prostate condition in an animal comprising a reagent that recognizes BRK protein and instructions for use.
2 . The kit of claim 1 , wherein the reagent that recognizes BRK protein is an antibody.Join the waitlist — get patent alerts
Track US2007037229A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.